{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T05:24:57Z","timestamp":1787808297498,"version":"build-2784847793"},"reference-count":61,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Science & Justice"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.scijus.2017.12.004","type":"journal-article","created":{"date-parts":[[2017,12,22]],"date-time":"2017-12-22T08:17:39Z","timestamp":1513930659000},"page":"219-225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["The use of a quantitative structure-activity relationship (QSAR) model to predict GABA-A receptor binding of newly emerging benzodiazepines"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9172-0828","authenticated-orcid":false,"given":"Laura","family":"Waters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieran R.","family":"Manchester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D.","family":"Maskell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Haegeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shozeb","family":"Haider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.scijus.2017.12.004_bb0005","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1111\/j.1360-0443.2011.03563.x","article-title":"Benzodiazepines revisited-will we ever learn?","volume":"106","author":"Lader","year":"2011","journal-title":"Addiction"},{"issue":"Suppl. S1","key":"10.1016\/j.scijus.2017.12.004_bb0010","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1002\/jat.810","article-title":"Bretazenil, a benzodiazepine receptor partial agonist, as an adjunct in the prophylactic treatment of op poisoning","volume":"21","author":"Tashma","year":"2001","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.scijus.2017.12.004_bb0015","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/jat.1556","article-title":"Ion channels in toxicology","volume":"30","author":"Restrepo-Angulo","year":"2010","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.scijus.2017.12.004_bb0020","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.drugalcdep.2012.07.004","article-title":"Polydrug abuse: a review of opioid and benzodiazepine combination use","volume":"125","author":"Jones","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.scijus.2017.12.004_bb0025","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2165\/00002018-200730030-00007","article-title":"Survey of forged prescriptions to investigate risk of psychoactive medications abuse in France: results of Osiap survey","volume":"30","author":"Boeuf","year":"2007","journal-title":"Drug Saf."},{"key":"10.1016\/j.scijus.2017.12.004_bb0030","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/BF00637747","article-title":"Use of prescription forgeries in a drug abuse surveillance network","volume":"36","author":"Bergman","year":"1989","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.scijus.2017.12.004_bb0035","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/dta.1628","article-title":"Characterization of the designer benzodiazepine Diclazepam and preliminary data on its metabolism and pharmacokinetics","volume":"6","author":"Moosmann","year":"2014","journal-title":"Drug Testing and Analysis."},{"key":"10.1016\/j.scijus.2017.12.004_bb0040","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3109\/15563650.2015.1112907","article-title":"Flubromazolam-a new life-threatening designer benzodiazepine","volume":"54","author":"\u0141ukasik-G\u0142\u0119bocka","year":"2016","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.scijus.2017.12.004_bb0045","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/dta.2003","article-title":"Detectability of designer benzodiazepines in Cedia, emit ii plus, Heia, and Kims ii immunochemical screening assays","volume":"9","author":"Bergstrand","year":"2017","journal-title":"Drug Testing and Analysis"},{"key":"10.1016\/j.scijus.2017.12.004_bb0050","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/dta.2099","article-title":"Detection of the designer benzodiazepine Metizolam in urine and preliminary data on its metabolism","volume":"9","author":"Kintz","year":"2016","journal-title":"Drug Testing and Analysis."},{"key":"10.1016\/j.scijus.2017.12.004_bb0055","article-title":"The emergence of new psychoactive substance (nps) benzodiazepines: a review","author":"Manchester","year":"2017","journal-title":"Drug Testing and Analysis"},{"key":"10.1016\/j.scijus.2017.12.004_bb0060","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/wps.20236","article-title":"Designer benzodiazepines: a new challenge","volume":"14","author":"Moosmann","year":"2015","journal-title":"World. Psychiatry."},{"key":"10.1016\/j.scijus.2017.12.004_bb0065","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.forsciint.2016.09.006","article-title":"Blood concentrations of new designer benzodiazepines in forensic cases","volume":"268","author":"H\u00f8iseth","year":"2016","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.scijus.2017.12.004_bb0070","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/0897190013515001","article-title":"Benzodiazepines: a major component in unintentional prescription drug overdoses with opioid analgesics","volume":"27","author":"Jann","year":"2014","journal-title":"J. Pharm. Pract."},{"key":"10.1016\/j.scijus.2017.12.004_bb0075","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3810\/pgm.2013.07.2684","article-title":"Risks, management, and monitoring of combination opioid, benzodiazepines, and\/or alcohol use","volume":"125","author":"Gudin","year":"2013","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.scijus.2017.12.004_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0264180100000412","article-title":"The natural history of tolerance to the benzodiazepines","volume":"13","author":"Higgitt","year":"1988","journal-title":"Psychol. Med. Monogr. Suppl."},{"key":"10.1016\/j.scijus.2017.12.004_bb0085","article-title":"Mechanisms underlying tolerance after long-term benzodiazepine use: a future for subtype-selective Gabaa receptor modulators?","volume":"416864","author":"Vinkers","year":"2012","journal-title":"Adv. Pharmacol. Sci."},{"key":"10.1016\/j.scijus.2017.12.004_bb0090","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/j.1360-0443.1994.tb03743.x","article-title":"The benzodiazepine withdrawal syndrome","volume":"89","author":"P\u00e9tursson","year":"1994","journal-title":"Addiction"},{"key":"10.1016\/j.scijus.2017.12.004_bb0095","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.forsciint.2015.07.033","article-title":"Phenazepam: a review of medico-legal deaths in South Scotland between 2010 and 2014","volume":"254","author":"Shearer","year":"2015","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.scijus.2017.12.004_bb0100","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.forsciint.2012.02.006","article-title":"Phenazepam abuse in Finland: findings from apprehended drivers, post-mortem cases and police confiscations","volume":"220","author":"Kriikku","year":"2012","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.scijus.2017.12.004_bb0105","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/hup.2222","article-title":"Phenazepam abuse in the Uk: an emerging problem causing serious adverse health problems, including death","volume":"27","author":"Corkery","year":"2012","journal-title":"Human Psychopharmacology."},{"key":"10.1016\/j.scijus.2017.12.004_bb0110","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.annemergmed.2014.12.019","article-title":"Overdose of Etizolam: the abuse and rise of a benzodiazepine analog","volume":"65","author":"O'Connell","year":"2014","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.scijus.2017.12.004_bb0115","first-page":"74","article-title":"Practical overview of quantitative structure-activity relationship","volume":"8","author":"Nantasenamat","year":"2009","journal-title":"EXCLI J."},{"key":"10.1016\/j.scijus.2017.12.004_bb0120","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/jat.2804","article-title":"Chemoinformatics and chemical genomics: potential utility of in silico methods","volume":"31","author":"Valerio Jr","year":"2012","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.scijus.2017.12.004_bb0125","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/dta.1593","article-title":"Predicting the activity and toxicity of new psychoactive substances: a pharmaceutical industry perspective","volume":"6","author":"Leach","year":"2013","journal-title":"Drug Testing and Analysis."},{"key":"10.1016\/j.scijus.2017.12.004_bb0130","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0015-7368(81)71392-6","article-title":"The use of quantitative structure-activity relationships as an aid to the interpretation of blood levels in gases of fatal barbiturate poisoning","volume":"21","author":"Moffat","year":"1981","journal-title":"J. Forensic Soc."},{"key":"10.1016\/j.scijus.2017.12.004_bb0135","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1021\/jm991074s","article-title":"A 3d-Qsar study on the structural requirements for binding to Cb1 and Cb2 cannabinoid receptors","volume":"43","author":"Fichera","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.scijus.2017.12.004_bb0140","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1021\/jm0610705","article-title":"The application of 3d-Qsar studies for novel cannabinoid ligands substituted at the C1' position of the alkyl side chain on the structural requirements for binding to cannabinoid receptors Cb1 and Cb2","volume":"50","author":"Durdagi","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.scijus.2017.12.004_bb0145","doi-asserted-by":"crossref","first-page":"6754","DOI":"10.1016\/j.bmcl.2007.10.044","article-title":"Combined 3d Qsar and molecular docking studies to reveal novel cannabinoid ligands with optimum binding activity","volume":"17","author":"Durdagi","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.scijus.2017.12.004_bb0150","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10822-006-9090-y","article-title":"3d-Qsar study of hallucinogenic Phenylalkylamines by using Comfa approach","volume":"21","author":"Zhang","year":"2007","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.scijus.2017.12.004_bb0155","first-page":"548","article-title":"Quasi-atomistic receptor surrogates for the 5-Ht2a receptor: a 3d-Qsar study on hallucinogenic substances","volume":"18","author":"Schulze-Alexandru","year":"1999","journal-title":"Molecular Informatics."},{"key":"10.1016\/j.scijus.2017.12.004_bb0160","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/7854_2016_18","article-title":"Decoding the structure of abuse potential for new psychoactive substances: structure\u2013activity relationships for abuse-related effects of 4-substituted Methcathinone analogs","volume":"32","author":"Negus","year":"2016","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.scijus.2017.12.004_bb0165","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s11094-009-0332-x","article-title":"Influence of the structure of substituted benzodiazepines on their pharmacokinetic properties","volume":"43","author":"Artemenko","year":"2009","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.scijus.2017.12.004_bb0170","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jflm.2011.12.014","article-title":"Phenazepam: the drug that came in from the cold","volume":"19","author":"Maskell","year":"2012","journal-title":"J. Forensic Legal Med."},{"key":"10.1016\/j.scijus.2017.12.004_bb0175","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/jat\/bku025","article-title":"Applying quantitative structure-activity relationship (Qsar) methodology for modeling postmortem redistribution of benzodiazepines and tricyclic antidepressants","volume":"38","author":"Giaginis","year":"2014","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.scijus.2017.12.004_bb0180","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.tiv.2009.09.009","article-title":"A tentative quantitative structure\u2013toxicity relationship study of benzodiazepine drugs","volume":"24","author":"Funar-Timofei","year":"2010","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.scijus.2017.12.004_bb0185","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/08927022.2014.888718","article-title":"Predictive toxicity modelling of benzodiazepine drugs using multiple in silico approaches: descriptor-based Qstr, group-based Qstr and 3d-Toxicophore mapping","volume":"41","author":"Kar","year":"2014","journal-title":"Mol. Simul."},{"key":"10.1016\/j.scijus.2017.12.004_bb0190","first-page":"1086","article-title":"De novo analysis of receptor binding affinity data of benzodiazepines","volume":"33","author":"Borea","year":"1983","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.scijus.2017.12.004_bb0195","first-page":"461","article-title":"Study of benzodiazepines receptor sites using a combined Qsar-Comfa approach","volume":"11","author":"Greco","year":"1993","journal-title":"Molecular Informatics."},{"key":"10.1016\/j.scijus.2017.12.004_bb0200","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0026-895X(25)10983-8","article-title":"Modeling the benzodiazepine receptor binding site by the general three-dimensional structure-directed quantitative structure-activity relationship method Remotedisc","volume":"37","author":"Ghose","year":"1990","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.scijus.2017.12.004_bb0205","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1021\/cr00030a002","article-title":"Quantitative structure-activity relationships of the benzodiazepines. A review and reevaluation","volume":"94","author":"Hadjipavlou-Litinat","year":"1994","journal-title":"Chem. Rev."},{"key":"10.1016\/j.scijus.2017.12.004_bb0210","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.1021\/jm960536o","article-title":"Genetic neural networks for quantitative structure-activity relationships: improvements and application of benzodiazepine affinity for benzodiazepine\/Gabaa receptors","volume":"39","author":"So","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.scijus.2017.12.004_bb0215","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1021\/jm00004a017","article-title":"Prediction of receptor properties and binding affinity of ligands to benzodiazepine\/Gabaa receptors using artificial neural networks","volume":"38","author":"Maddalena","year":"1995","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.scijus.2017.12.004_bb0220","series-title":"Advances in Drug Research","first-page":"165","article-title":"Recent advances in the molecular pharmacology of benzodiazepine receptors and in the structure-activity relationships of their agonists and antagonists","author":"Haefely","year":"1984"},{"key":"10.1016\/j.scijus.2017.12.004_bb0225","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1747-0285.2007.00605.x","article-title":"Atomic property fields: generalized 3d Pharmacophoric potential for automated ligand superposition, pharmacophore elucidation and 3d Qsar","volume":"71","author":"Totrov","year":"2008","journal-title":"Chem. Biol. Drug Des."},{"issue":"Supplement 1","key":"10.1016\/j.scijus.2017.12.004_bb0230","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1186\/1471-2105-12-S1-S35","article-title":"Ligand binding site superposition and comparison based on atomic property fields: identification of distant homologues, convergent evolution and Pdb-wide clustering of binding sites","volume":"12","author":"Totrov","year":"2011","journal-title":"BMC Bioinformatics."},{"key":"10.1016\/j.scijus.2017.12.004_bb0235","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/jcc.540150503","article-title":"Icm\u2014a new method for protein modeling and design: applications to docking and structure prediction from the distorted native conformation","volume":"15","author":"Abagyan","year":"1994","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.scijus.2017.12.004_bb0240","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1021\/acs.jcim.6b00371","article-title":"Structural and Physico-chemical interpretation (Spci) of Qsar models and its comparison with matched molecular pair analysis","volume":"56","author":"Polishchuk","year":"2016","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.scijus.2017.12.004_bb0245","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0076-6879(03)74020-8","article-title":"Modeller: generation and refinement of homology-based protein structure models","volume":"374","author":"Fiser","year":"2003","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.scijus.2017.12.004_bb0250","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1021\/acs.jctc.6b00049","article-title":"Htmd: high-throughput molecular dynamics for molecular discovery","volume":"12","author":"Doerr","year":"2016","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.scijus.2017.12.004_bb0255","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"Procheck: a program to check the Stereochemical quality of protein structures","volume":"26","author":"Laskowski","year":"1993","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.scijus.2017.12.004_bb0260","doi-asserted-by":"crossref","first-page":"W407","DOI":"10.1093\/nar\/gkm290","article-title":"Prosa-web: interactive web Service for the Recognition of errors in three-dimensional structures of proteins","volume":"35","author":"Wiederstein","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.scijus.2017.12.004_bb0265","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1021\/ci049885e","article-title":"Ligandscout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters","volume":"45","author":"Wolber","year":"2005","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.scijus.2017.12.004_bb0270","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1021\/jm4004285","article-title":"Qsar modeling: where have you been? Where are you going to?","volume":"57","author":"Cherkasov","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.scijus.2017.12.004_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/ci400572x","article-title":"Data set Modelability by Qsar","volume":"54","author":"Golbraikh","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.scijus.2017.12.004_bb0280","series-title":"Handbook of Psychopharmacology: Biochemical Studies of Cns Receptors","first-page":"285","article-title":"Benzodiazepine receptors","author":"Braestrup","year":"1983"},{"key":"10.1016\/j.scijus.2017.12.004_bb0285","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1139\/v87-269","article-title":"Benzodiazepine stereochemistry: crystal structures of the diazepam antagonist Ro 15-1788 and the anomalous benzodiazepine Ro 5-4864","volume":"65","author":"Hempel","year":"1987","journal-title":"Can. J. Chem."},{"key":"10.1016\/j.scijus.2017.12.004_bb0290","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1021\/acs.biochem.6b00142","article-title":"Translocator protein 18Kda (Tspo): an old protein with new functions?","volume":"55","author":"Li","year":"2016","journal-title":"Biochemistry"},{"key":"10.1016\/j.scijus.2017.12.004_bb0295","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/glia.21091","article-title":"Translocator protein (18kda) (Tspo)\/peripheral benzodiazepine receptor (Pbr) specific ligands induce microglia functions consistent with an activated state","volume":"59","author":"Choi","year":"2011","journal-title":"Glia"},{"key":"10.1016\/j.scijus.2017.12.004_bb0300","first-page":"893","article-title":"Racemation of the benzodiazepines Camazepam and Ketazolam and receptor binding of enantiomers","volume":"36","author":"Blaschke","year":"1986","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.scijus.2017.12.004_bb0305","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/0028-3908(83)90113-2","article-title":"Benzodiazepine receptor ligands with positive and negative efficacy","volume":"22","author":"Braestrup","year":"1983","journal-title":"Neuropharmacology"}],"container-title":["Science & Justice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1355030617301545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1355030617301545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T04:06:30Z","timestamp":1751169990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1355030617301545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S1355030617301545"],"URL":"https:\/\/doi.org\/10.1016\/j.scijus.2017.12.004","relation":{},"ISSN":["1355-0306"],"issn-type":[{"value":"1355-0306","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of a quantitative structure-activity relationship (QSAR) model to predict GABA-A receptor binding of newly emerging benzodiazepines","name":"articletitle","label":"Article Title"},{"value":"Science & Justice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.scijus.2017.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Chartered Society of Forensic Sciences. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}